Metal binding to the amyloid-β peptides in the presence of biomembranes: potential mechanisms of cell toxicity.


Journal

Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry
ISSN: 1432-1327
Titre abrégé: J Biol Inorg Chem
Pays: Germany
ID NLM: 9616326

Informations de publication

Date de publication:
12 2019
Historique:
received: 04 06 2019
accepted: 10 09 2019
pubmed: 29 9 2019
medline: 11 8 2020
entrez: 29 9 2019
Statut: ppublish

Résumé

The amyloid-β (Aβ) peptides are key molecules in Alzheimer's disease (AD) pathology. They interact with cellular membranes, and can bind metal ions outside the membrane. Certain oligomeric Aβ aggregates are known to induce membrane perturbations and the structure of these oligomers-and their membrane-perturbing effects-can be modulated by metal ion binding. If the bound metal ions are redox active, as e.g., Cu and Fe ions are, they will generate harmful reactive oxygen species (ROS) just outside the membrane surface. Thus, the membrane damage incurred by toxic Aβ oligomers is likely aggravated when redox-active metal ions are present. The combined interactions between Aβ oligomers, metal ions, and biomembranes may be responsible for at least some of the neuronal death in AD patients.

Identifiants

pubmed: 31562546
doi: 10.1007/s00775-019-01723-9
pii: 10.1007/s00775-019-01723-9
doi:

Substances chimiques

Amyloid beta-Peptides 0
Reactive Oxygen Species 0
Copper 789U1901C5
Iron E1UOL152H7

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1189-1196

Auteurs

Sebastian K T S Wärmländer (SKTS)

Arrhenius Laboratories, Department of Biochemistry and Biophysics, Stockholm University, 106 91, Stockholm, Sweden.

Nicklas Österlund (N)

Arrhenius Laboratories, Department of Biochemistry and Biophysics, Stockholm University, 106 91, Stockholm, Sweden.

Cecilia Wallin (C)

Arrhenius Laboratories, Department of Biochemistry and Biophysics, Stockholm University, 106 91, Stockholm, Sweden.

Jinming Wu (J)

Department of Biology and Chemistry, Paul Scherrer Institut, 5232, Villigen, Switzerland.

Jinghui Luo (J)

Department of Biology and Chemistry, Paul Scherrer Institut, 5232, Villigen, Switzerland.

Ann Tiiman (A)

Department of Clinical Neuroscience (CNS), Center for Molecular Medicine CMM L8:01, Karolinska Institutet, Stockholm, Sweden.

Jüri Jarvet (J)

Arrhenius Laboratories, Department of Biochemistry and Biophysics, Stockholm University, 106 91, Stockholm, Sweden.
The National Institute of Chemical Physics and Biophysics, Tallinn, Estonia.

Astrid Gräslund (A)

Arrhenius Laboratories, Department of Biochemistry and Biophysics, Stockholm University, 106 91, Stockholm, Sweden. astrid.graslund@dbb.su.se.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH